TIMOTHY A SPRINGER, a director at $RNAC ($RNAC), bought 5,181 shares of the company on 12-23-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 0.1%. Following this trade, they now own 8,507,895 shares of $RNAC stock.
$RNAC Insider Trading Activity
$RNAC insiders have traded $RNAC stock on the open market 39 times in the past 6 months. Of those trades, 22 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $RNAC stock by insiders over the last 6 months:
- TIMOTHY A SPRINGER has traded it 21 times. They made 21 purchases, buying 697,866 shares and 0 sales.
- METIN KURTOGLU (Chief Technology Officer) has traded it 12 times. They made 0 purchases and 12 sales, selling 134,721 shares.
- CHRISTOPHER M JEWELL (Chief Scientific Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 52,115 shares.
- MILOS MILJKOVIC (Chief Medical Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 55,000 shares.
- TIMOTHY C BARABE purchased 7,500 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RNAC Hedge Fund Activity
We have seen 36 institutional investors add shares of $RNAC stock to their portfolio, and 45 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 2,341,054 shares (+458.3%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 994,632 shares (-100.0%) from their portfolio in Q2 2024
- CITADEL ADVISORS LLC added 375,767 shares (+inf%) to their portfolio in Q3 2024
- MPM BIOIMPACT LLC added 369,727 shares (+142.4%) to their portfolio in Q3 2024
- CM MANAGEMENT, LLC removed 305,482 shares (-100.0%) from their portfolio in Q2 2024
- ARTAL GROUP S.A. removed 304,554 shares (-100.0%) from their portfolio in Q3 2024
- INVESCO LTD. removed 244,699 shares (-100.0%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.